Type 2 Diabetes, the World's First Combination of Weekly Insulin and Semaglutide: 52 Annual Injections Compared to over 1000. The Availability of the Medicine Could Start From Italy.
4 Articles
4 Articles
The Committee for Medicinal Products for Human Use (Chmp) of the European Regulatory Agency Ema is to place the first combination of basal insulin on the market...
Diabetes, Ok Ema for the First Combination of Weekly Insulin and Semaglutide - Five Columns Magazine
(Adnkronos) - The Committee for Medicinal Products for Human Use (Chmp) of the European Regulatory Agency Ema to the placing on the market of the first combination of weekly basal insulin icodec and weekly semaglutide, IcoSema. The new option combines in a single formulation two medicinal products with complementary mechanisms of action and has been developed to promote... Read more The article Diabetes, ok Ema for the first combination of weekl…
Type 2 diabetes free from Ema experts to the new therapeutic option that should improve adherence to treatment This article Type 2 diabetes, first ok from Ema to new treatment with one injection per week comes from LaPresse
Following the analysis of clinical evidence on glycaemic control, body weight and episodes of hypoglycaemia, the positive opinion from the CHMP (EMA) comes in for therapeutic innovation that can reduce the number of doses and simplify treatment. The first European availability could start right from Italy
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
